Weekly Roundup: January 3-7

ICYMI, this week we had stories on the continued issues with iPLEDGE, the new data on spesolimab treatment for GPP, and more.

POLL: Which Recent Drug Pipeline Move is Most Exciting?

Safety and Efficacy of JAK Inhibitors

Key opinion leaders explain the box warnings and safety profiles of JAK inhibitors.

New Data Released on Spesolimab Treatment for GPP

New research has been published in the New England Journal of Medicine on spesolimab as a treatment for generalized pustular psoriasis.

CDC halves COVID isolation recommendation for people without symptoms

But mask-wearing still vital to slowing spread of disease, agency says.

All-Purpose Hair Transplant Graft Harvester Study Shows Potential Capabilities

FUE is a type of hair transplant that requires physicians to change tools to accommodate different hair and scalp types. Now, a recent study highlights a single device aiming to treat all types of hair situations.

9 Investigators Receive Grants for Eczema Research

The new research will investigate many factors of the skin disease like changes over lifetime, new therapy pathways, and the science behind itch and inflammation.

Reviewing Clinical Trial Data for JAK Inhibitors

Matthew Zirwas, MD, breaks down the safety of JAK inhibitors based on clinical trial data.

Plaque Psoriasis Case 1: Patient Counseling and Approaching Therapy

Centering discussion on a case of plaque psoriasis, experts share their experience with patient counseling and selecting therapy.

Pointers with Dr Portela: TikTok’s Green Mask Stick

In this week’s Pointers with Dr Portela, the 208SkinDoc had already called out the Green Mask Stick’s false advertising, but now the controversy continues.

Plaque Psoriasis Case 1: Selecting a Therapeutic Class

The panel reviews therapeutic classes and their respective benefits in patients being treated for plaque psoriasis.

SOCS 2021 Achievement Highlights

The Skin of Color Society released an article detailing its 2021 achievements, containing what the society considers its most active and successful year.

Nearly Two-Thirds Still Locked Out of iPLEDGE

A survey conducted by Dermatology Times® found that many still cannot access the iPLEDGE system. Now some have created guides to get around the issue.

FDA Accepts IND for RM-1995 Photoimmunotherapy in Advanced Cutaneous or Head and Neck SCC

The FDA has accepted an investigational new drug application for the photoimmunotherapy treatment, RM-1995, for patients with advanced cutaneous squamous cell carcinoma or head and neck squamous cell carcinoma.

Impact of Itch Sparks New Pipeline Direction

Skin sensitivity will be a factor in vehicles for new treatments.

Digital Device Aids Skin Cancer Diagnostics

Skin cancer dermoscopy is getting a hightech overhaul as the scope of innovation broadens from a singular focus on the stand-alone product to the development of a comprehensive medical, patient care, and workflow management platform.